Allergan Unit Must Face Bulk Of Namenda Pay-For-Delay Suit
Allergan subsidiary Forest Laboratories LLC must face a jury over a union health and welfare fund's class action antitrust claims that pay-for-delay deals kept generic versions of Alzheimer's drug Namenda off...To view the full article, register now.
Already a subscriber? Click here to view full article